IMMUNE DESIGN CORP's ticker is IMDZ and the CUSIP is 45252L103. A total of 73 filers reported holding IMMUNE DESIGN CORP in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $3,000 | – | 585 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ProQuest Associates IV LLC | 1,962,720 | $39,411,000 | 7.61% |
| NEXTHERA CAPITAL LP | 40,000 | $803,000 | 1.14% |
| SECTORAL ASSET MANAGEMENT INC | 856,867 | $17,206,000 | 0.73% |
| Cormorant Asset Management, LP | 189,000 | $3,795,000 | 0.45% |
| SPHERA FUNDS MANAGEMENT LTD. | 153,000 | $3,072,000 | 0.45% |
| RS INVESTMENT MANAGEMENT CO LLC | 1,108,576 | $22,260,000 | 0.20% |
| Eventide Asset Management | 180,000 | $3,614,000 | 0.18% |
| Focused Wealth Management, Inc | 12,898 | $259,000 | 0.15% |
| Vident Investment Advisory, LLC | 38,384 | $771,000 | 0.10% |
| OXFORD ASSET MANAGEMENT LLP | 56,248 | $1,166,000 | 0.03% |